DK0862634T4 - Farmaceutisk præparat mod papillomavirustumorer og -infektioner - Google Patents

Farmaceutisk præparat mod papillomavirustumorer og -infektioner

Info

Publication number
DK0862634T4
DK0862634T4 DK97935646T DK97935646T DK0862634T4 DK 0862634 T4 DK0862634 T4 DK 0862634T4 DK 97935646 T DK97935646 T DK 97935646T DK 97935646 T DK97935646 T DK 97935646T DK 0862634 T4 DK0862634 T4 DK 0862634T4
Authority
DK
Denmark
Prior art keywords
infections
pharmaceutical preparation
polypeptide
iii
papillomavirus
Prior art date
Application number
DK97935646T
Other languages
English (en)
Other versions
DK0862634T3 (da
Inventor
Jean-Marc Balloul
Nadine Bizouarne
Marie-Paule Kieny
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494633&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0862634(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of DK0862634T3 publication Critical patent/DK0862634T3/da
Application granted granted Critical
Publication of DK0862634T4 publication Critical patent/DK0862634T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
DK97935646T 1996-07-30 1997-07-29 Farmaceutisk præparat mod papillomavirustumorer og -infektioner DK0862634T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609584A FR2751879B1 (fr) 1996-07-30 1996-07-30 Composition pharmaceutique contre les tumeurs et infections a papillomavirus
PCT/FR1997/001412 WO1998004705A1 (fr) 1996-07-30 1997-07-29 Composition pharmaceutique contre les tumeurs et infections a papillomavirus

Publications (2)

Publication Number Publication Date
DK0862634T3 DK0862634T3 (da) 2002-01-21
DK0862634T4 true DK0862634T4 (da) 2006-05-08

Family

ID=9494633

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01109013T DK1149910T3 (da) 1996-07-30 1997-07-29 Farmaceutisk præparat til behandling af papillomavirustumorer og -infektion
DK97935646T DK0862634T4 (da) 1996-07-30 1997-07-29 Farmaceutisk præparat mod papillomavirustumorer og -infektioner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK01109013T DK1149910T3 (da) 1996-07-30 1997-07-29 Farmaceutisk præparat til behandling af papillomavirustumorer og -infektion

Country Status (12)

Country Link
EP (2) EP1149910B1 (da)
JP (2) JP4070815B2 (da)
AT (2) ATE205881T1 (da)
AU (1) AU736720B2 (da)
CA (1) CA2234263C (da)
DE (2) DE69728914T2 (da)
DK (2) DK1149910T3 (da)
ES (2) ES2215805T3 (da)
FR (1) FR2751879B1 (da)
HK (1) HK1043809B (da)
PT (2) PT862634E (da)
WO (1) WO1998004705A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020039584A1 (en) 1998-02-20 2002-04-04 Medigene Ag Papilloma virus capsomere vaccine formulations and methods of use
CA2229955C (en) 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
US7182947B2 (en) 1998-02-20 2007-02-27 Medigene Ag Papillomavirus truncated L1 protein and fusion protein constructs
US7494658B2 (en) 1998-02-20 2009-02-24 Medigene Ag Papilloma virus truncated L1 protein and fusion protein constructs
US6926897B1 (en) 1998-03-24 2005-08-09 Medigene Aktiengesellschaft Medicament for the avoidance or treatment of papillomavirus-specific tumour
CA2335506A1 (en) * 1998-06-26 2000-01-06 Aventis Pasteur Mucosal targeting immunisation
DK2530161T3 (da) * 2006-06-20 2018-06-06 Transgene Sa Fremgangsmåde til fremstilling af poxvira og poxvirussammensætninger
BRPI1006901A2 (pt) 2009-01-20 2016-02-16 Transgène S A método ex vivo e kit para testar se um paciente responderá terapeuticamente a um método de tratamento, e, uso de níveis de sicam-1 em uma amostra de sangue
HUE026194T2 (en) 2009-03-24 2016-05-30 Transgene Sa Biomarker for checking patients
RU2555340C2 (ru) 2009-04-17 2015-07-10 Трансжене Са Биомаркер для мониторинга пациентов
CA2761457A1 (en) 2009-05-12 2010-11-18 Transgene Sa Immortalized avian cell lines and use thereof
DK2452194T3 (da) 2009-07-10 2015-11-30 Transgene Sa Biomarkør til patientudvælgelse og beslægtede fremgangsmåder
SG178090A1 (en) 2009-07-21 2012-03-29 Transgene Sa Enzymatic composition for the digestion of chicken embryos
TWI690322B (zh) 2012-10-02 2020-04-11 法商傳斯堅公司 含病毒的調配物及其使用
MX2017007178A (es) 2014-12-01 2017-08-28 Transgene Sa Formulaciones liquidas estables de virus de vacuna.
FR3042121A1 (fr) * 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
CA3062549A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
KR20200003921A (ko) 2017-05-15 2020-01-10 얀센 백신스 앤드 프리벤션 비.브이. 안정한 바이러스-함유 조성물
CA3111273C (en) 2018-09-06 2024-03-26 Bavarian Nordic A/S Storage improved poxvirus compositions
WO2021180943A1 (en) 2020-03-12 2021-09-16 Bavarian Nordic A/S Compositions improving poxvirus stability

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2643817B1 (fr) * 1989-03-06 1993-12-17 Transgene Sa Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
AU650868B2 (en) † 1990-03-20 1994-07-07 Behringwerke Aktiengesellschaft Seroreactive epitopes of human papillomavirus (HPV) 16 proteins
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
DE122007000019I1 (de) * 1991-07-19 2007-07-26 Univ Queensland Impfstoffen gegen Papillomavirus
US5618536A (en) * 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
IL113817A (en) * 1994-06-30 2001-03-19 Merck & Co Inc Polynucleotide for vaccination against the umbilical cord virus
CA2201592A1 (en) * 1994-10-03 1996-04-18 The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
GB9505784D0 (en) * 1995-03-22 1995-05-10 Lynxvale Ltd Anti-tumour treatment
FR2749323B1 (fr) * 1996-06-04 1998-07-10 Pasteur Merieux Serums Vacc Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique

Also Published As

Publication number Publication date
HK1043809B (zh) 2004-12-03
PT862634E (pt) 2002-03-28
DK1149910T3 (da) 2004-08-02
DE69728914D1 (de) 2004-06-03
JP4198735B2 (ja) 2008-12-17
EP0862634B1 (fr) 2001-09-19
JP4070815B2 (ja) 2008-04-02
ES2163795T3 (es) 2002-02-01
DE69728914T2 (de) 2005-04-07
CA2234263C (fr) 2009-10-13
FR2751879B1 (fr) 1998-10-30
ES2215805T3 (es) 2004-10-16
WO1998004705A1 (fr) 1998-02-05
JP2007254474A (ja) 2007-10-04
AU736720B2 (en) 2001-08-02
EP0862634A1 (fr) 1998-09-09
AU3855297A (en) 1998-02-20
CA2234263A1 (fr) 1998-02-05
EP1149910A1 (fr) 2001-10-31
EP1149910B1 (fr) 2004-04-28
EP0862634B2 (fr) 2006-03-01
DE69706825T2 (de) 2002-05-02
DE69706825T3 (de) 2006-08-24
DK0862634T3 (da) 2002-01-21
ATE205881T1 (de) 2001-10-15
HK1043809A1 (en) 2002-09-27
PT1149910E (pt) 2004-09-30
JP2000500662A (ja) 2000-01-25
ATE265535T1 (de) 2004-05-15
FR2751879A1 (fr) 1998-02-06
DE69706825D1 (de) 2001-10-25
ES2163795T5 (es) 2006-07-16

Similar Documents

Publication Publication Date Title
DK0862634T4 (da) Farmaceutisk præparat mod papillomavirustumorer og -infektioner
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
NO924172L (no) Substituerte bifenylpyridoner
FI891361A (fi) Menetelmä farmaseuttisesti vaikuttavien aryylihydratsonien valmistamiseksi
EA200200479A1 (ru) Новые олигосахариды, их получение и содержащие их фармацевтические композиции
AU589939B2 (en) Medical composition for injection containing a spergualin as active ingredient and process for preparing the same
FI923347A (fi) Blodfaktorer producerade med rekombinant-dna-teknik och foerfarande foer expression av naemnda blodfaktorer samt i naemnda foerfarande anvaenda rekombinanta kokoppvirus.
CS156792A3 (en) Substituted diaminophthalimides and compounds analogous thereto
KR0180256B1 (en) Bpc peptides, their preparation and use
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
EP0127124A3 (en) Compounds for treating hypertension
MY101169A (en) Novel phenylureas
EP1074264A4 (en) NEOVASCULARIZATION INHIBITORS
AU6722498A (en) Disubstituted biphenyloxazolines
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
IT8821003A0 (it) Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/ 4 (idrossidifenilmetil) 1piperidinbutanolo".
RU94019328A (ru) α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ
IT1230053B (it) Composizione per l'aumento del guadagno di peso.
IT8619383A0 (it) Nuovi composti ad attivita'colinergica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8619384A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
IT8719352A0 (it) Nuovi composti ad attivita'colinergica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
CA2234611A1 (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions